GB0422644D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0422644D0
GB0422644D0 GBGB0422644.5A GB0422644A GB0422644D0 GB 0422644 D0 GB0422644 D0 GB 0422644D0 GB 0422644 A GB0422644 A GB 0422644A GB 0422644 D0 GB0422644 D0 GB 0422644D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0422644.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Nordic Bioscience AS
Original Assignee
Novartis AG
Nordic Bioscience AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33443790&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB0422644(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG, Nordic Bioscience AS filed Critical Novartis AG
Priority to GBGB0422644.5A priority Critical patent/GB0422644D0/en
Publication of GB0422644D0 publication Critical patent/GB0422644D0/en
Priority to EP05795076A priority patent/EP1802328A1/en
Priority to MX2007004259A priority patent/MX2007004259A/es
Priority to CNA2005800339490A priority patent/CN101035556A/zh
Priority to BRPI0516872-4A priority patent/BRPI0516872A/pt
Priority to KR1020077008224A priority patent/KR20070061864A/ko
Priority to JP2007536066A priority patent/JP2008515947A/ja
Priority to AU2005293802A priority patent/AU2005293802A1/en
Priority to US11/577,127 priority patent/US20090048157A1/en
Priority to PCT/EP2005/010892 priority patent/WO2006040114A1/en
Priority to CA002580766A priority patent/CA2580766A1/en
Priority to RU2007117492/14A priority patent/RU2007117492A/ru
Priority to TW094135420A priority patent/TW200628168A/zh
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/225—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB0422644.5A 2004-10-12 2004-10-12 Organic compounds Ceased GB0422644D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB0422644.5A GB0422644D0 (en) 2004-10-12 2004-10-12 Organic compounds
RU2007117492/14A RU2007117492A (ru) 2004-10-12 2005-10-10 Применение органических соединений
CA002580766A CA2580766A1 (en) 2004-10-12 2005-10-10 Use of organic compounds
KR1020077008224A KR20070061864A (ko) 2004-10-12 2005-10-10 유기 화합물의 용도
MX2007004259A MX2007004259A (es) 2004-10-12 2005-10-10 Uso de compuestos organicos.
CNA2005800339490A CN101035556A (zh) 2004-10-12 2005-10-10 有机化合物的用途
BRPI0516872-4A BRPI0516872A (pt) 2004-10-12 2005-10-10 uso de compostos orgánicos
EP05795076A EP1802328A1 (en) 2004-10-12 2005-10-10 Use of organic compounds
JP2007536066A JP2008515947A (ja) 2004-10-12 2005-10-10 有機化合物の使用
AU2005293802A AU2005293802A1 (en) 2004-10-12 2005-10-10 Use of organic compounds
US11/577,127 US20090048157A1 (en) 2004-10-12 2005-10-10 Use of organic compounds
PCT/EP2005/010892 WO2006040114A1 (en) 2004-10-12 2005-10-10 Use of organic compounds
TW094135420A TW200628168A (en) 2004-10-12 2005-10-11 Use of organic compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0422644.5A GB0422644D0 (en) 2004-10-12 2004-10-12 Organic compounds

Publications (1)

Publication Number Publication Date
GB0422644D0 true GB0422644D0 (en) 2004-11-10

Family

ID=33443790

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0422644.5A Ceased GB0422644D0 (en) 2004-10-12 2004-10-12 Organic compounds

Country Status (13)

Country Link
US (1) US20090048157A1 (https=)
EP (1) EP1802328A1 (https=)
JP (1) JP2008515947A (https=)
KR (1) KR20070061864A (https=)
CN (1) CN101035556A (https=)
AU (1) AU2005293802A1 (https=)
BR (1) BRPI0516872A (https=)
CA (1) CA2580766A1 (https=)
GB (1) GB0422644D0 (https=)
MX (1) MX2007004259A (https=)
RU (1) RU2007117492A (https=)
TW (1) TW200628168A (https=)
WO (1) WO2006040114A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2469709C2 (ru) * 2005-11-17 2012-12-20 Новартис Аг Фармацевтическая композиция
CN102292346B (zh) 2009-01-22 2015-12-02 关键生物科学有限公司 肥胖的治疗
EP2773365B1 (en) * 2011-11-02 2016-07-20 KeyBioscience AG Peptide analogs for treating diseases and disorders
BR112014010701A2 (pt) * 2011-11-02 2020-06-23 Keybioscience Ag Uso de um peptídeo
US9533022B2 (en) 2011-11-02 2017-01-03 KeyBioscience A/S Peptide analogs for treating diseases and disorders
CN107345965A (zh) * 2016-05-04 2017-11-14 广州优迪生物科技有限公司 一种同时检测N-MID和β-CTX的双标记时间分辨荧光免疫分析方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
GB9108634D0 (en) * 1991-04-23 1991-06-12 Ciba Geigy Pharmaceutical compositions
DE726075T1 (de) * 1995-02-08 1996-12-12 Therapicon Srl Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
IT1282374B1 (it) * 1996-01-31 1998-03-20 Therapicon Srl Composizioni farmaceutiche parenterali a base di calcitonine sintetiche a ph controllato con basso indice di dolorosita'
EP1175390B1 (en) * 1999-04-05 2005-02-02 Emisphere Technologies, Inc. Disodium salts, monohydrates, and ethanol solvates
US7049283B2 (en) * 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
US20040110170A1 (en) * 2002-05-18 2004-06-10 The Regents Of The University Of California Cloning and characterization of calcitonin gene related peptide receptors
TW200411053A (en) * 2002-12-30 2004-07-01 Ind Tech Res Inst Nucleic acid encoding recombinant salmon calcitionin, expression vector thereof, and method for producing recombinant salmon calcitonin therewith

Also Published As

Publication number Publication date
RU2007117492A (ru) 2008-11-20
WO2006040114A1 (en) 2006-04-20
AU2005293802A1 (en) 2006-04-20
BRPI0516872A (pt) 2008-09-23
KR20070061864A (ko) 2007-06-14
JP2008515947A (ja) 2008-05-15
US20090048157A1 (en) 2009-02-19
MX2007004259A (es) 2007-05-11
EP1802328A1 (en) 2007-07-04
CN101035556A (zh) 2007-09-12
TW200628168A (en) 2006-08-16
CA2580766A1 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
GB0410712D0 (en) Organic compounds
GB0409921D0 (en) Organic compounds
GB0403038D0 (en) Organic compounds
GB0407723D0 (en) Organic compounds
GB0404434D0 (en) Organic compounds
GB0405289D0 (en) Organic compounds
GB0401334D0 (en) Organic compounds
GB0402797D0 (en) Organic compounds
GB0408078D0 (en) Organic compounds
GB0400781D0 (en) Organic compounds
GB0422644D0 (en) Organic compounds
GB0403115D0 (en) Organic compounds
GB0406515D0 (en) Organic compounds
GB0403254D0 (en) Organic compounds
GB0405723D0 (en) Organic compounds
GB0409236D0 (en) Organic compounds
GB0406240D0 (en) Organic compounds
GB0407468D0 (en) Organic compounds
GB0407607D0 (en) Organic compounds
GB0405898D0 (en) Organic compounds
GB0405034D0 (en) Organic compounds
GB0405900D0 (en) Organic compounds
GB0407467D0 (en) Organic compounds
GB0403964D0 (en) Organic compounds
GB0402682D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)